IN-DATE
MAS9513: Masimo SedLine Sedation Monitor Kit w/MOC-9 Module & RD SedLine Patient Cable, Lithium Battery
Sign in to add this product to your favorites!
| Price: | $999.00 per kit |
|---|---|
| Quantity: | |
| In Stock: | 3 kits |
| Status: | Non-sterile |
Additional Details
Masimo 9513 SedLine Sedation Monitor Kit
- For use with Root and RD SedLine Sensors
- The SedLine Module computes and calculates PSi and additional parameters using the EEG signals acquired from the SedLine Sensor
- The module connects Root to the SedLine Patient Cable and receives its power from Root
- SedLine Patient Cable transfers analog EEG signals collected from the SedLine Sensor to the SedLine Module for processing
- Patient cable is reusable and may be used from patient to patient.
Product Code: 9513
AccessGUDID Info
- FDA Product Code: GWQ
- FDA Product Code Name: Full-montage Standard Electroencephalograph
- GMDN Term Code: 37323
- GMDN Term Name: Patient monitoring system module, electroencephalographic
- GMDN Term Description: A small unit dedicated to detect and record the electrical activity of the brain in the form of an electroencephalogram (EEG). The electrical activity of the brain is detected via electrodes affixed to the patient's forehead or scalp. It is designed to operate as part of a patient monitoring system enhancing the function of this system (the parent device). The module automatically plugs into the parent device when the user places it into a standardized slot in the parent device which operates as a mainframe computer displaying the signals measured and provided by this module. It may also register auditory evoked potentials (AEP) signals.
Manufacturer
Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo Rainbow Pulse CO-Oximetry and new Masimo noninvasive and continuous total hemoglobin (SpHb™) monitoring technology. The recent introduction of the first-and-only FDA-cleared technology that noninvasively and continuously measures total hemoglobin without a painful needle stick and invasive blood draw is expected to open new markets and significantly expand the company’s growth opportunities.
